Research

LEAP Study

The LEAP Study showed that including peanut protein in infant diets for 5 years reduced allergy risk by 80% compared to avoidance.

EAT Study

The EAT Study showed that including a diversity of potentially allergenic proteins (peanut, egg, wheat, dairy, fish, sesame) was safe in infants as young as 3 months of age. It further showed the rate of any food allergy was reduced by 2/3 in people who followed the inclusion protocol. At the same time, the study revealed notable challenges with this approach, in that fewer than half of those in the “early introduction arm” were able to successfully adhere to the long-term inclusion protocol. (SpoonfulOne was developed to address this by being more comprehensive and convenient)

I'M EATING Study

SpoonfulOne was tested for safety and tolerability in infants by researchers at Northwestern University via a randomized, blinded, placebo-controlled, nationwide, in-home study in more than 700 infants. This study demonstrated no allergic events either at the first feeding when SpoonfulOne was introduced in these children or in any of the subsequent feedings over the weeks that followed. This top-line data was presented at the Pediatric Allergy and Asthma Meeting in London in 2017.

American Academy of Allergy Asthma and Immunology

Since 2012, the American Academy of Allergy Asthma and Immunology’s Adverse Reactions to Foods task force has stated that all the potentially allergenic foods can be safely fed to healthy infants beginning around 4-6 months of age.

NIH / NIAID and The American Academy of Pediatrics - Updated Guidelines

NIH / NIAID and The American Academy of Pediatrics reacted to the LEAP Study by issuing formal guidelines noting that “early and often” peanut inclusion in infant diets may reduce the risk of developing a peanut allergy.

General

Our Products

My Account

LEAP Study

EAT Study

I'M EATING Study

American Academy of Allergy Asthma and Immunology

NIH / NIAID and The American Academy of Pediatrics - Updated Guidelines